Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?

Overview Forecast RevenueFinancials Chart

Bicycle Therapeutics Ownership Summary

Bicycle Therapeutics is owned by 93.30% institutional investors, 1.31% insiders, and 5.39% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 22.09% of BCYC shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.93% of its assets in Bicycle Therapeutics shares.

BCYC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Bicycle Therapeutics	93.30%	1.31%	5.39%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Baker bros. advisors lp	9.40M	22.09%	$190.26M
Deep track capital, lp	3.49M	8.20%	$70.65M
Ra capital management	2.25M	5.29%	$45.60M
Fcpm iii services b.v.	2.12M	4.99%	$42.97M
Armistice capital	1.97M	4.63%	$39.91M
Westfield capital management co lp	1.52M	3.58%	$30.84M
Tybourne capital management (hk)	1.51M	3.55%	$30.56M
First light asset management	1.38M	3.25%	$28.03M
Morgan stanley	1.23M	2.89%	$24.93M
Fairmount funds management	1.07M	2.51%	$21.64M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Fcpm iii services b.v.	2.12M	6.34%	$42.97M
Tybourne capital management (hk)	1.51M	6.21%	$30.56M
Aquilo capital management	156.69K	3.06%	$3.17M
First light asset management	1.38M	2.46%	$28.03M
Fairmount funds management	1.07M	2.44%	$21.64M
Baker bros. advisors lp	9.40M	2.43%	$190.26M
Deep track capital, lp	3.49M	2.11%	$70.65M
Parkman healthcare partners	535.06K	1.45%	$10.83M
Highvista strategies	127.25K	0.94%	$2.58M
Alphacentric advisors	60.00K	0.89%	$1.21M

Top Buyers

Holder	Shares	% Assets	Change
Baker bros. advisors lp	9.40M	2.43%	4.46M
Fcpm iii services b.v.	2.12M	6.34%	2.12M
Ra capital management	2.25M	0.60%	1.45M
Fairmount funds management	1.07M	2.44%	1.07M
Ecor1 capital	910.00K	0.56%	910.00K

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	-	-	-3.25M
Suvretta capital management	-	-	-914.48K
Avoro capital advisors	-	-	-700.00K
Woodline partners lp	-	-	-586.62K
Morgan stanley	1.23M	0.00%	-285.14K

New Positions

Holder	Shares	% Assets	Change	Value
Fcpm iii services b.v.	2.12M	6.34%	2.12M	$42.97M
Fairmount funds management	1.07M	2.44%	1.07M	$21.64M
Ecor1 capital	910.00K	0.56%	910.00K	$18.42M
Perceptive advisors	572.00K	0.27%	572.00K	$11.58M
Aquilo capital management	156.69K	3.06%	156.69K	$3.17M

Sold Out

Holder	Change
Zurcher kantonalbank (zurich cantonalbank)	-4.00
Mather group, llc.	-5.00
Northwestern mutual wealth management	-5.00
Gen-wealth partners	-39.00
Group one trading	-91.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	107	11.46%	39,708,441	30.36%	93	1.81%	60	42.86%	25	-24.24%
Mar 31, 2024	96	-10.28%	30,461,275	-2.88%	71	1.14%	42	-25.00%	33	3.13%
Dec 31, 2023	107	2.88%	31,365,344	-3.19%	79	0.69%	56	-6.67%	32	39.13%
Sep 30, 2023	104	18.18%	32,400,076	33.05%	107	1.63%	60	53.85%	23	-17.86%
Jun 30, 2023	88	-8.33%	24,351,184	3.42%	81	1.32%	39	-23.53%	28	55.56%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
T. Rowe Price Health Sciences	1.33M	1.93%	33.87K
Polar Capital Biotech S Inc	1.00M	1.45%	-
Harbor Small Cap Growth Instl	847.47K	1.23%	151.69K
Westfield Capital Mgt Co Sm-Cap Gr Eq	695.78K	1.01%	234.44K
Candriam Eqs L Biotech C USD Cap	558.46K	0.81%	103.02K
BNP Paribas Health Cr Innovtr Cl Cap	524.80K	0.76%	-70.78K
Candriam Global Equities Oncology	492.11K	0.71%	125.18K
Belfius Equities Cure C Cap	492.11K	0.71%	-
AXA Framlington Health Fund - R Income	273.98K	0.40%	-
iShares Biotechnology ETF	272.78K	0.40%	-1.63K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 11, 2024	Thompson Travis Alvin	CHIEF ACCOUNTING OFFICER	Sell	$5.18K
Nov 11, 2024	Thompson Travis Alvin	CHIEF ACCOUNTING OFFICER	Sell	$81.71K
Nov 11, 2024	Thompson Travis Alvin	CHIEF ACCOUNTING OFFICER	Sell	$27.78K
Nov 11, 2024	Thompson Travis Alvin	CHIEF ACCOUNTING OFFICER	Sell	$3.85K
Nov 11, 2024	Thompson Travis Alvin	CHIEF ACCOUNTING OFFICER	Sell	$5.73K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	11
2024 Q3	-	7
2024 Q2	-	7
2024 Q1	-	6
2023 Q4	-	6

BCYC Ownership FAQ

Who Owns Bicycle Therapeutics?

Bicycle Therapeutics shareholders are primarily institutional investors at 93.30%, followed by 1.31% insiders and 5.39% retail investors. The average institutional ownership in Bicycle Therapeutics's industry, Biotech Stocks , is 44.97%, which Bicycle Therapeutics exceeds.

Who owns the most shares of Bicycle Therapeutics?

Bicycle Therapeutics’s largest shareholders are Baker bros. advisors lp (9.4M shares, 22.09%), Deep track capital, lp (3.49M shares, 8.20%), and Ra capital management (2.25M shares, 5.29%). Together, they hold 35.58% of Bicycle Therapeutics’s total shares outstanding.

Does Blackrock own Bicycle Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Bicycle Therapeutics.

Who is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.34% of its assets in 2.12M Bicycle Therapeutics shares, valued at 42.97M$.

Who is the top mutual fund holder of Bicycle Therapeutics shares?

T. Rowe Price Health Sciences is the top mutual fund holder of Bicycle Therapeutics shares, with 1.93% of its total shares outstanding invested in 1.33M Bicycle Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools